Management of first trimester miscarriage after implementation of a standardized protocol in a tertiary hospital in Cape Town, South Africa – an observational study by Breidenthal, Anne Guri
	 i	
 
 
Management of first trimester miscarriage after implementation of a standardized 
protocol in a tertiary hospital in Cape Town, South Africa – an observational study 
 
 
Dr Anne Guri Breidenthal 
 
 
 
 
 
Supervisor: Dr Judy Kluge 
 
 
 
 
 
Thesis presented in partial fulfilment of the requirements for the degree of Master of 
Medicine Obstetrics and Gynaecology in the Faculty of Medicine at Stellenbosch University 
 
December 2017 
 
	 ii	
 
 
 
 
 
Declaration 
 
By submitting this dissertation electronically, I declare that the entirety of the work contained 
therein is my own, original work, that I am the sole author thereof, that reproduction and 
publication thereof by Stellenbosch University will not infringe any third party rights and that 
I have not previously in its entirety or in part submitted it for obtaining any qualification.”  
 
Date: December 2017 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © 2017 Stellenbosch University  
All rights reserved 
Stellenbosch University  https://scholar.sun.ac.za
	 iii	
Abstract - English 
Background 
Spontaneous first trimester miscarriage is common problem in primary care and emergency 
settings. Management options have changed over time and now include surgical, medical and 
expectant management options.  
Aim 
 To assess the effectiveness and complications of these various choices   for women with first 
trimester miscarriages who present to an acute and outpatient early pregnancy service, 
Tygerberg hospital, a tertiary level public hospital in Cape Town, South Africa. Prior to this 
the standard practice was surgical management of first trimester miscarriages 
Methods 
A protocol introducing the various management options of first trimester miscarriages was 
created and implemented, and an audit was carried out over six months to assess outcomes 
between January 2015 and June 2015. Data was captured and analyzed with SPSS software 
using Kaplan-Meier analysis and Pearson Chi-square test. 
Results 
Of the 157 women whose management of their miscarriage was assessed, 32% had surgical, 
40% had medical and 28% had expectant management. Median days until complete 
miscarriage was 1 [1 -66 days] for surgical, 10 [1 – 105 days] for medical and 18 [1 – 66 
days] for expectant management. All patients who chose initial surgical management 
completed the miscarriage in that category. Seventy-five percent of women who intended 
medical management and 18.4% who chose expectant management successfully completed 
the miscarriage as initially planned. The remainder completed their miscarriages in the 
medically or surgically. Complication rates included: 10.2% blood transfusions, 5.1% sepsis, 
1.3% misoprostol side-effects, and 0.6% re-evacuations. 
Conclusion 
Surgical management is the quickest and most effective option followed by medical and 
expectant management. Complication rates were high, reflecting the inclusion of unstable 
patients requiring urgent surgical management. Medical and expectant management should 
only be offered to stable low risk women. Counselling should include the time taken to 
completed miscarriage and the possible need to change the management method. This allows 
women to choose a management option best suited to them. 
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Abstrak - Afrikaans 
Agtergrond 
Spontane miskrame in die eerste trimester van swangerskap is ‘n algemene probleem in 
primêre sorg klinieke en noodeenhede. Die verskillende opsies vir hantering het verander oor 
die afgelope jare en daar is nou chirurgiese, mediese and afwagtende opsies beskikbaar.  
Doel 
Die doel van hierdie studie was om die effektiwiteit van hierdie verskillende behandelings 
opsies te ondersoek asook om die komplikasies te beskryf in vrouens wat met eerste trimester 
miskrame by ‘n noodeenheid sowel as buitepasiënt kliniek by Tygerberg Hospitaal hanteer 
word.   Tygerberg Hospitaal is ‘n sekondêre en tersiêre verwysingshospitaal in Kaapstad, 
Suid Afrika. Die roetine hantering voor hierdie studie was chirurgie. 
Metodes 
Die studie volg na die skryf en implementering van ‘n nuwe protokol wat al die verskillende 
hanteringsopsies aanbied. ‘n Oudit vir die eerste ses maande na implementering is uitgevoer.  
Dataverwerking is uitgevoer met behulp van die SPSS sagtewarepakket en Kaplan-Meier 
oorlewings analises sowel as die Pearson Chi-kwadraat toets is gebruik waar nodig. 
Resultate 
Daar was 157 pasiënte in die studie en van hulle het 32% chirurgiese hantering gehad, 40% 
het mediese behandeling ontvang en 28% afwagtende of konserwatiewe hantering. Die 
mediaan vir die aantal dae tot die miskraam volledig was, was 1 dag (1-66 dae) vir chirurgie; 
10 dae (1-105 dae) vir die mediese groep en 18 dae (1-66 dae) vir die groep met afwagtende 
hantering. Die vrouens wat die chirurgiese opsie gekies het, het slegs hierdie behandeling 
benodig. Van die mediese behandeling groep het 75% en van die konserwatiewe groep het 
18.4% slegs die aanvanklike metode benodig en die res het addisionele chirurgiese of mediese 
behandeling benodig. Die komplikasies sluit bloedoortapping (10.2%), sepsis (5.1%), newe-
effekte van misoprostol (1.3%) en herhaal ledigings van die uterus (0.6%) in. 
Gevolgtrekking 
Die mees effektiewe metode is chirurgie en daarna is dit mediese en dan afwagtende 
hantering. Daar was ‘n redelike hoë voorkoms van komplikasies, meesal as gevolg van 
onstabiele pasiënte wat chirurgie benodig het. Mediese sowel as konserwatiewe hantering  
moet net aan lae risiko vrouens wat heeltemal stabiel is aangebied word. Tydens raadgewing 
moet vrouens ingelig word oor die tydsduur van die verskillende metodes en die moontlikheid 
dat ‘n tweede opsie nodig kan raak. Dit sal vrouens toelaat om ‘n keuse te maak oor die 
metode wat die beste vir hulle sal werk. 	
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Introduction   
Spontaneous miscarriage is one of the commonest reasons for acute presentation to 
gynaecologists, which occurs in 10.9–30% of all early pregnancies.1,2 The 2014 
Saving Mothers Report indicated that 4.3% of maternal deaths in South Africa 
happened due to miscarriages, a marginal increase from 3.5% in 2002-2004. The 185 
women who died from miscarriages in the past triennium signify that their 
management is still an important priority as these deaths should be avoidable. 3   
According to Fawcus et al. sharp surgical curettage of the uterus was standard of care 
for managing miscarriages in South Africa in 1997, used 96.4% of the time, and 
manual vacuum aspiration (MVA) was used in 2.8%. Most cases were done under 
general anaesthetic (GA) in an operating theatre.4 This was still the reality in 2002 
when Jewkes et al. assessed management of incomplete miscarriages in all public 
hospitals in all nine provinces in South Africa where 82% received sharp curettage, 
2.5% suction curettage and 14.8% MVA5. Moodliar et al. did a randomized trial in 
Durban in 2005 showing 91.5% effectiveness with medical management using 600 
micrograms of misprostol, a prostaglandin E analogue with uterotonic properties, 
after 14 days follow-up. It was as safe, effective, and acceptable to women compared 
with sharp curettage under GA. In this setting where the comparison is medical versus 
surgical management under GA, medical management could be a cost saver in a 
resource constrained setting.6  
Expectant, or conservative management involves allowing spontaneous passage of 
retained products of conception without intervention, but requires follow up of the 
patient. Medical management usually involves the use of Misoprostol to aid expulsion 
of retained products. Surgical management involves evacuation of the uterus with 
various MVA, suction aspiration or sharp curettage under local anaesthetic or GA in 
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an unstable patient.7 MVA is related to fewer complications compared with sharp 
curettage of the uterus, and hence vacuum aspiration is World Health Organization 
surgical technique of choice.8,9  
The UK MIST trial from 2006 is one of the landmark trials proving that giving a 
stable woman the choice between expectant, medical and surgical management is safe 
and satisfactory for women.10 Expectant management involves no treatment to the 
patient, but continued follow-up to assess whether the miscarriage has resolved 
spontaneously. The National Institute of Clinical Excellence and Royal College of 
Obstetrics and Gynaecology (NICE/RCOG) guidelines from 2012 advise that 
expectant management should be first line for the first 7 to 14 days in stable cases, 
with appropriate counseling and follow-up. After the initial wait, one can still offer 
medical management or surgical management as clinically indicated.7 Table 1 
provides a summary of the advantages and disadvantages of the three methods of 
management of a first trimester miscarriage in a stable patient. 
	
Table	1:	Summary	of	advantages	and	disadvantages	of	the	various	methods	of	miscarriage	
management	
Summary of methods 
 Expectant 
 
Medical Surgical 
Advantages • Avoids surgical and 
anaesthetic risk 
• Allows women to 
continue daily routine 
• More acceptable to 
some women 
• Avoids surgical and 
anaesthetic risk 
• Faster resolution 
compared with 
expectant management 
• Planned and predictable 
treatment 
• High success rate 
• Essential in unstable 
patient 
Dis-
advantages 
• May have more 
prolonged bleeding  
• Timescale and 
outcome not 
predictable 
• 23-50% may need 
• Greater analgesic need 
• More vaginal bleeding 
• 29-38% of cases may 
need surgical 
evacuation10 
• Risk of unscheduled 
• Risk of anaesthetic (less 
if local) 
• Risk of uterine 
perforation and cervical 
trauma, and intrauterine 
adhesions 
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surgical evacuation10 
• Risk of unscheduled 
evacuation if heavy 
bleeding occurs  
evacuation if heavy 
bleeding occurs  
• Side effects of 
misoprostol: diarrhoea, 
vomiting, pyrexia. 
 
Despite the evidence available, surgical evacuation of the uterus was mainstay of 
treatment of miscarriages at Tygerberg hospital. Alternative methods were not 
routinely used. 
The aim of this study was to assess the effectiveness and adverse events of the 
surgical, medical and expectant management options in women with first trimester 
miscarriage presenting to a public gynaecology service after implementing a new 
protocol. This was done by creating a protocol, implementing the protocol and 
auditing the outcomes. 
Literature review 
Definitions 
When reviewing the literature on miscarriages there are different definitions and 
terminology used depending on continent and context. In the UK, the combined 
RCOG and NICE guideline say a miscarriage is the loss of an intrauterine pregnancy 
before 24 completed weeks of gestation 7. The World Health Organization (WHO) 
define a miscarriage as “the expulsion from its mother of an embryo or foetus 
weighing 500 g or less with no signs of life”, corresponding to a gestational age of 20 
- 22 completed weeks of gestation. Miscarriages are classified as early, or first 
trimester if they occur before 12 full weeks (12+6), and second trimester if they occur 
between 13+0 and 24+0 weeks of gestation. 11 
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European Society for Human reproduction and Embryology (ESHRE) define first 
trimester up to week 12, and second trimester from 12 – 24 weeks12. This protocol 
used the RCOG and WHO definition. 
 
Diagnosis 
History and examination is imperative in diagnosing miscarriages, the most common 
presenting complaint being vaginal bleeding. Last menstrual period (LMP), bleeding 
pattern and pain, must be elicited to help distinguish it from other causes of bleeding. 
Transvaginal ultrasound (TVUS) is routinely used to confirm intrauterine position of 
pregnancy, and there are various criteria used to diagnose the different types of 
miscarriages.13 
Crown rump length (CRL) should be measured with the fetus in a neutral position, 
from crown to rump, excluding the yolk sac. The inter-observer variation of CRL has 
been reported as 15%, so the cut-off of seeing a fetal heart at 5mm previously used 
has increased to 7mm, as some of the pregnancies with CRL of 5-7mm subsequently 
developed into viable pregnancies.  
Gestational sac (GS) size should be measured as the mean sac diameter (average of 
the sagittal, transverse, and antero-posterior (AP) diameters of the sac). The inter-
observer variation of GS has been reported to be 19%, so the GS size of 25mm is felt 
to give the best specificity and positive predictive value of 100%.14   
Missed miscarriage is a term that is used in the NICE/RCOG guideline, but is not 
widely used in the literature. It is an umbrella term and incorporates “missed 
abortion”, “anembryonic pregnancy”, “blighted ovum”,  “early fetal demise”, “non-
viable pregnancy” and “ early embryonic death”.7 WHO used the term “missed 
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abortion” when doing the review of misoprostol for treating first trimester miscarriage 
in 2007, but the term miscarriage is now preferred over abortion.2,15 
Incomplete miscarriage, with retained products of conception can be clinically 
suspected if there is persistent or increased bleeding, abdominal pain, fever and 
endometritis, or if the bleeding does not start for a missed miscarriage. Ultrasound 
will show irregular heterogeneous echoes within the endometrial cavity, and the AP 
endometrial lining is more than 15mm. However, studies of ultrasound appearances 
after uterine evacuation for first trimester terminations have shown that in an 
asymptomatic patient active intervention is not necessary.16 Management of retained 
products of conception can be expectant7,10, medical or surgical with MVA or 
hysteroscopy17. 
A diagnosis of a complete miscarriage can only be made when a prior intrauterine 
pregnancy was seen on ultrasound, and if this is not the case it has to be called 
‘pregnancy of unknown location’ and followed up with serum human chorionic 
gonadotrophin (hCG). In a study by Condous they found that 5.9% of 152 women 
with apparent complete miscarriage on TVUS had ectopic pregnancy when followed 
up with serial hCG.18 
Pregnancy of uncertain viability is a term that has been used increasingly after some 
cases had been reported where women were told they had a miscarriage but ended up 
with a viable pregnancy. This is not only potential cases for litigation but can also be 
very distressing for women. NEJM published guidelines for diagnosing definite 
pregnancy failure, and features suspicious of failure, from an expert consensus group. 
These features are similar to the criteria to diagnose miscarriages, but also add 
timelines for repeating scans to ensure the accuracy of diagnosis. 14  
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History, examination and investigation of miscarriages 
Any patient with a suspected miscarriage, who presents with vaginal bleeding and has 
a positive pregnancy test, should always be assessed according to the ABC principle 
(Airway-Breathing-Circulation) to ensure the mother is stable, then a good history 
and examination should be conducted.7 
As a minimum the following should be elicited from the history: 
• Age, Gravity, Parity 
• LMP, pregnancy test done in 
this pregnancy 
• Pain: Site, onset, character, 
radiation, alleviating/associated 
symptoms, timing, 
exacerbating factors, severity   
• Vaginal bleeding: duration and 
severity 
• Passage of products of 
conception 
• Medical history 
• Surgical history 
• Gynaecological history: 
menstrual cycle, last Pap 
Smear, contraception use, risk 
factors for ectopic pregnancy
 
The following risk factors are present up to 23% of patients with an ectopic 
pregnancy according to the NICE/RCOG guidelines. On average 37% of women have 
no risk factors recorded. 
• Previous pelvic inflammatory 
disease 
• Previous tubal/abdominal 
surgery 
• Previous ectopic pregnancy 
• Assisted reproduction 
• Infertility 
• Conceiving with IUCD or on 
the progesterone only pill 
• Conceiving after sterilization 
failure 
• Multiple sexual partners   
• Endometriosis 
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The examination should be thorough and focus on looking for signs and symptoms of 
shock and any organ dysfunction due to inadequate perfusion, which would require 
urgent action. 
• Observations: blood pressure, pulse, respiratory rate, temperature,  
• Sideroom investigations: haemoglobin (Hb), urine pregnancy test,  
• General cardiovascular and respiratory examination 
• Abdominal examination: masses, guarding, rebound, location of pain 
• Gynaecological exam: 
o Speculum: Cervical os: open or closed, Offensive discharge, Presence 
of necrotic cervical tissue/ cervical trauma 
o Bimanual examination: Cervical excitation tenderness, size of uterus, 
Adnexal masses or tenderness 
TVUS can then be done with consent if indicated by history and examination, using 
the diagnostic criteria mentioned above. 
Treatment options 
Modern management of miscarriages has been described in guidelines for more than 
10 years. The well-recognized WHO/FIGO, American and European professional 
colleges have produced guidelines on management of early miscarriages, as per 
summaries found below.  
Table	2:	Overview	of	management	options		
Incomplete and Missed miscarriage 
 NICE/RCOG7 ACOG19 WHO and FIGO20 
Expectant Reassurance, 
emergency contact, 
analgesia. Follow-up 
14 days 
Education, 
reassurance, 
emergency contact, 
analgesia. Follow-up 
14 days but allow up 
to 8 weeks 
n/a 
Medical  
(dose of 
misoprostol 
Incomplete: 
600 mcg po or sl 
Missed: 
800 mcg pv, can 
repeat dose after 3h 
up to 7 days.  
Follow up 7 – 14 
Incomplete: 600 
mcg po or 400 mcg 
sl 
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in mcg) 800 mcg po/sl can 
repeat dose after 
24h. 
Follow up 14 days. 
days  Missed: 
800 mcg pv or 600 
mcg sl, can repeat 
dose after 3hours. 
Follow-up 7 -14 
days. 
Surgical MVA, setting not 
specified 
MVA in office 
setting under local 
anaesthetic 
n/a 
 
Evidence for current management 
The MIST trial from 2006 is one of the most robust sources of evidence available for 
management of miscarriages. It was a randomized controlled trial that compared 
expectant vs. medical vs. surgical management in 1200 women with miscarriage 10. 
They included women at less than 13 weeks’ gestation who had been diagnosed as 
having either an incomplete miscarriage or missed miscarriage (early fetal/embryonic 
demise). Women with severe haemorrhage or pain, pyrexia above 37.5°C, severe 
asthma, haemolytic disease or blood dyscrasias, current anticoagulation or systemic 
corticosteroid treatment, twin or higher order pregnancy, who were smokers aged 
over 35, and unable to understand written English were excluded. Their definition of 
incomplete miscarriage was “areas of mixed echogenicity within the uterine cavity 
with or without a disordered gestation sac”. Early embryonic demise defined as 
“intact gestation sac of greater than 20 mm mean diameter with no other internal 
structures”, and early fetal demise as “a fetus of over 6 mm crown- rump length with 
no heart activity on TVUS”. 
Their protocol for expectant management was giving the women a specific 
information sheet on miscarriage, 30 tables with a paracetamol-dihydrocodeine 
combination, and an emergency telephone number.  
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The medical management arm differed between the incomplete miscarriage and 
missed miscarriage groups; incomplete miscarriages were admitted to hospital and 
given a single vaginal dose of 800 mcg misoprostol.  Women with missed miscarriage 
were pre-treated with a single oral dose of 200 mg mifepristone, and then admitted to 
hospital 24-48 hours later for a single vaginal dose of 800 mcg misoprostol. A 
surgical procedure was offered if expulsion of retained products had not started within 
eight hours of insertion of misoprostol.  
Women in the surgical management arm were admitted for suction curettage under 
GA. No prophylactic antibiotics were used at the time of curettage. 
The group managed medically, had 29% unplanned surgical curettages of incomplete 
miscarriages, and 38% unplanned procedures for early pregnancy failures. The 
expectantly management group had 23% unplanned surgical curettages in the 
incomplete miscarriage group, and 50% unplanned procedures in the early pregnancy 
failure group. 
Materials and Methods 	
Setting  
Tygerberg hospital serves a catchment area of 1 874 586 people in the Metro East part 
of Cape Town in South Africa, a upper middle income country.21 The gynaecology 
emergency admissions area services 362 patients per month according to the 2015 
Tygerberg hospital annual report. It is manned 24 hours a day by a professional nurse 
with every patient being assessed by an onsite registrar (specialist in training) and 
intern with the availability of an offsite consultant if needed. During the week, a day-
theatre is available between 07.30 – 15.00, for performing MVAs under local 
anaesthetic. When emergencies occur after-hours, or if the patient is too unstable for 
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the procedure under local anaesthetic, a main theatre, and a labour ward theatre within 
the hospital with emergency staffing on site can be used for emergency cases. 
Methods 
In 2014 an evidence-based protocol was written at Tygerberg, which was primarily 
based on the NICE/RCOG guideline, and tailored it to the local context.7 It was the 
first structured protocol in this hospital on alternative methods of managing first 
trimester miscarriages (see Appendix 1). Staff were educated on the protocol at 
academic meetings, informal teaching of registrars (specialists in training), and 
physical copies of protocols were distributed in key clinical areas.  
Patients with first trimester miscarriage up to 12+6 weeks of pregnancy were assessed 
and classified as stable or unstable using the following hemodynamic parameters 
(pulse >90 bpm, blood pressure >90/50 mmHg, respiratory rate > 20/min, and 
temperature > 37.5 0C), clinical signs (foul smelling products, uterus >12 weeks size, 
organ dysfunction, clinical signs of infection) or side room investigations (Hb < 10.0 
g/dL), as per Appendix 1. Stable patients with miscarriages were counselled and 
given the choice of their management, as per protocol. Unstable patients were offered 
surgical method only. Ectopic pregnancies, pregnancy of unknown location and molar 
pregnancies were not addressed in the protocol. 
Miscarriages were defined as first trimester if they were less than 13 weeks by LMP, 
clinically, or by scan.  Registrars in the gynaecology admission area did the scans 
using the following definitions as defined in the protocol, and if there were any 
uncertainty, a formal scan by the ultrasound department would be done.  
• Incomplete miscarriage was diagnosed if the anterior posterior (AP) diameter of 
the irregular heterogeneous echoes was ≥15 mm on TVUS).  
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• Missed miscarriage was defined as:  
o a) Empty GS:  ≥25 mm mean GS diameter with no visible embryo or yolk 
sac 
o b) Presence of an intrauterine GS of <25 mm in which an embryo did not 
become visible on repeat scan after at least 7 days 
o c) Embryo with CRL ≥ 7mm with no visible heart activity  
o d) Initial visualization of an embryo or fetus with visible heart activity <7 
mm followed by a repeat scan showing an absence of heart activity.7,22  
• Complete miscarriage was diagnosed if AP diameter of uterus was <15 mm, and 
if prior intrauterine pregnancy had been seen on USS or products of conception 
visualised by attending doctor. If this were not the case the patient would be 
followed up in early pregnancy clinic to rule out ectopic pregnancy. 
All patients had booking bloods (Rhesus, RPR, RVD) drawn if the referring clinician 
had not done this, and acted on as needed. Rhesus negative women were offered Anti-
D immunoglobulin (Rhogam ®) 250 IU (50 micrograms) as per NICE guidelines.7 
Future family planning choices were discussed with all patients, and was provided by 
family planning unit as per patient choice, or advised to attend local clinic if the 
service was declined.  
• Expectant management involved counselling patients on what to expect in terms 
of bleeding and pain, providing them with non steroidal anti-inflammatory 
(NSAID) (Ibuprofen 400mg 8hrly), explaining warning signs (temperature, heavy 
PV bleeding ie soaking >2 pads per hour for >2hours, foul smelling discharge, 
severe pain not responding to NSAID), and providing them with an appointment 
in the early pregnancy clinic 10 to 14 days later. 
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• Medical management involved counselling as above, and providing 600 
micrograms Misoprostol sublingually for incomplete miscarriages, and 800 
micrograms Misoprostol sublingually for missed miscarriages.  The patients were 
advised that if no bleeding occurred within 24 hours, they should return for a 
repeat dose. They were offered follow-up 10 - 14 days later in the early pregnancy 
clinic. 
• Surgical management involved arranging for MVA in the day theatre under local 
anaesthetic, either on the same day if in office hours, or to return at the next 
available opportunity to have it done. Patients too unstable to wait were booked in 
main theatres or labour ward theatres for evacuation of the uterus. 
Data collection 
Data was collected for patients presenting between 1 January 2015 and 30 June 2015, 
and patients were followed up until discharge, or lost to follow-up. Patients were 
identified from the gynaecology emergency admission register, crosschecked with 
early pregnancy clinic registers and theatre registers, and notes were reviewed 
retrospectively. A data collection sheet was implemented, see Appendix 2. 
336 records were reviewed for eligibility; 157 had complete information enabling 
them to be included, 86 had other diagnoses like ectopic pregnancies and pregnancy 
of unknown location and 93 women were assessed but excluded. Of these 93, 18 of 
them had incomplete crucial information such as missing gestational age making it 
unclear whether it was first or second trimester, and 75 had missing notes. Attempts 
were made to retrieve missing notes from medical record department but were not 
successful.  
Aims and objectives 
The aim of this study was to assess the effectiveness and adverse events of the 
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surgical, medical and expectant management options in women with first trimester 
miscarriage presenting to a public gynaecology service after implementing a new 
protocol. This was done by creating a protocol, implementing the protocol and 
auditing the primary and secondary outcomes. 
Primary outcomes 
• Days until completed miscarriage 
• Percentage of women who completed their miscarriage with the original method 
chosen: those who started with a specific method, and had confirmed complete 
miscarriage with the same method were counted. The denominator was all of the 
women starting off in that category minus the loss to follow-up. 
Secondary outcomes 
• Complication rate (including need for blood transfusion, infection needing IV 
treatment, misoprostol side-effect requiring hospital admission, need for re-
evacuation of uterus). 
Statistics 
Data was analysed using Kaplan-Meier analysis for the survival analysis, and women 
were included in the survival analysis until they completed their miscarriage, or lost-
to-follow-up. The Pearson Chi-square test was used to assess categorical baseline 
data, and one-way ANOVA used for baseline continuous variables.  
Ethics 
Ethics-Committee (HREC) approval was obtained (S/14/10/246) from Stellenbosch 
University.   
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Results  
157 women were assessed for first trimester miscarriage over the six months. 50 had 
surgical management (MVA in day theatre if stable and evacuation of uterus in main 
theatre if unstable), 63 had medical management, and 44 had expectant management 
to start with. 
 
Figure	1:	Method	used	to	start,	by	initial	method	chosen	
 
The mean age of patients was comparable, as was the gestational age at which they 
presented as per Table 3. There was a significant difference with lower gestational 
age in the expectant group (p <0.001). There were more nulliparous patients in the 
expectant group (34.1%) as opposed to the surgical (24.0%) and medical (15.9%) 
groups respectively. The proportion of stable miscarriages as determined by the 
protocol were 44.0% in the surgical group, 85.7% in the medical group and 84.1% in 
the expectant group, indicating protocol violations. 
Surgical
32%
Medical
40%
Expectant
28%
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Table	3:	Patient	characteristics,	Classified	by	initial	method	
Characteristic Surgical (n = 50) Medical (n = 63) Expectant (n = 44) P values 
Mean (SD) age (years)  30.0 (7.1) 31.3 (7.3) 29.8 (7.0) 0.515 
Nulliparous % (n) 24.0 (12)  15.9 (10) 34.1 (15) 0.100 
Mean gestational  (SD) 
age (weeks) 
9.7 (2.1) 9.9 (2.2) 8.1 (2.6) <0.001 
≥1 Previous 
miscarriage % (n) 
20.0 (10) 22.2 (14) 31.8 (14) 0.356 
Stable (Safe 
miscarriage) % (n) 
44.0 (22) 85.7 (54) 84.1 (37) <0.001 
Mean haemoglobin 
(SD) (mg/mmol) 
10.6 (2.3) 12.1 (1.5) 11.7 (1.5) <0.001 
HIV pos % (n) 8.0 (4) 12.7 (8) 11.4 (5) 0.099 
HIV unknown % (n) 32.0 (16) 25.4 (16) 9.1 (4)  
HIV negative % (n) 60.0 (30) 61.9 (39) 79.5 (35)  
Type of miscarriage    <0.001 
Incomplete 68.6 (35) 53.2 (33) 15.9 (7)  
Missed 29.4 (15) 46.8 (29) 34.1 (15)  
Uncertain 
viability 
0 (0) 2 .0 (1) 50.0 (22)  
 
The time to event analysis looked at time from presentation until complete 
miscarriage, see Figure 2. Patients follow the survival curve of their original category 
(intention to treat analysis), and they were censored when they were lost to follow-up. 
Chi-square test was done with p = 0.001, indicating a significant difference in days 
until complete miscarriage between the groups. 
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Figure	2:	Kaplan-Meier	survival	on	days	from	presentation	until	complete	miscarriage	and	
discharge	based	on	initial	method	
 
 
All patients following up achieved the main end point of a complete miscarriage, 
however, not all completed it in their original category, as seen in Table 4. 
 
	
Table	4:	Primary	outcomes	
 Surgical (n = 
50) 
Medical (n = 
63) 
Expectant (n = 
44) 
P values 
Days until 
complete 
miscarriage 
Median [range] 
1 [1,67] 10 [1,105] 18 [1,66] <0.001 
Completed 
miscarriage in 
100 (50/50)* 75 (36/48)** 18.4 (7/38)** <0.001 
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original 
category % (n) 
Loss to follow-
up 
0 (0) 31.7 (20) 13.6 (6) 0.001 
* 1 patient needed re-evacuation, ** Loss to follow up (LTFU) excluded, but crossovers 
included 
 
Complications were commonest in the surgical group. The details of which are 
indicated in Table 5.  Two experienced misoprostol side-effects severe enough to 
require hospital admission. 
Table	5:	Secondary	outcomes	recorded	as	per	original	category	
* 4 Patients had both blood transfusion and sepsis 
Sixty-three patients started with medical management of their miscarriage. Of those, 
12 (19%) failed to achieve complete miscarriage and had surgical management, as per 
Figure 3. Of these 12 patients, 8 had one dose of misoprostol, 2 had two doses and 2 
had three doses of either 600 or 800 micrograms as per protocol for incomplete and 
Secondary 
outcome 
Surgical  
(n = 50) 
Medical  
(n = 63) 
Expectant 
(n = 44) 
Total      (n 
= 157) 
P values 
Complications % 
(n) 
32.0 (16) * 9.5 (6) 2.3 (1) 14.7 (23) <0.001 
Blood 
transfusion  
26.0 (13) 3.2 (2) 2.3 (1) 10.2 (16) <0.001 
Infection  12.0 (6)  3.2 (2) - 5.1 (8) 0.026 
Side effect 
(Misoprost
ol) 
- 3.2 (2) - 1.3 (2) 0.212 
Re-
evacuation 
2.0 (1) - - 0.6 (1)  
Repeat miso dose 
(2 or more)  % (n) 
- 19.0 (12) 9.0 (4) 10.1 (16)  
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missed miscarriage respectively.  On average, 1.19 doses of misoprostol were needed, 
the median being 1. 
Forty-four patients started with expectant management. Fifteen (34%) of these did not 
achieve complete miscarriage, and chose surgical management.  Another 16 (36%) 
changed to medical management. Thirteen (30%) completed their management 
expectantly, but 6 of these patients were lost to follow-up.   
50 patients had surgical management from the start, but had 12 patients added from 
medical group, and 15 from the expectant group. One of the patients in the surgical 
group needed re-evacuation of the uterus. 
	
Figure	3:	Flow	of	patients	through	the	clinical	system	
 
 
 
Medical
Chosen at start of 
study
• N = 63
Failed and chose 
surgical
• N = 12
Crossed over from 
expectant
• N = 16
Final number after 
crossovers 
• N = 67
• Of which 20 was lost to 
follow-up (15 from med, 
5 who crossed over from 
expectant)
Surgical
Chosen at start of 
study 
• N = 50
Crossed over from 
medical and 
expectant
• N = 27
Final number after 
crossovers 
• N = 77
• No Loss to follow-up
Expectant
Chosen at start of 
study
• N = 44
Failed and chose 
surgical
• N = 15
Failed and chose 
medical
• N = 16
Final number after 
crossovers 
• N = 13
• Of which 6 was lost to 
follow-up
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Discussion 
 
Principal findings    
The patient population was similar with regards to age and parity, but there was a 
statistically significant lower gestational age in the expectant group, probably as the 
pregnancies initially were of uncertain viability and the diagnosis of miscarriage was 
only confirmed at re-evaluation 10 – 14 days later as per protocol.  
All unstable patients, which included patients with Hb <10.0g/dl, should have been 
managed surgically as this is the quickest way to diminish vaginal bleeding caused by 
a miscarriage and as a result there were more unstable patients in the surgical group. 
There were 14.3% of women in the medical group and 15.9% in the expectant group 
that were unstable as defined in the protocol, and should have been managed as such.  
This might have been an intentional protocol violation as the service at times has 
limited bed availability, limited theatre access after-hours, and some patients, despite 
the haemoglobin being below the threshold, were deemed to be stable. Of the protocol 
violations, none suffered complications of bleeding or infection, but two needed an 
evacuation on return. Clinicians included patient’s ability to return to the facility in 
the decision-making when considering options.  
For the primary outcome of time to complete miscarriage, surgical management is 
understandably the most effective with median days till completion of 1 day, for 
medical it is 10 days and for expectant it is 18 days. There are outliers that complicate 
the survival graph as per Figure 2. Some experienced retained products needing 
several courses of misoprostol, clinic follow-up, and one patient eventually had a 
hysteroscopy with surgical evacuation under USS guidance to evacuate the uterus 
with histology showing fibrosed retained products of pregnancy. There might have 
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been an over-diagnosis of retained products of conception as our definition of 
complete miscarriage was ultrasound finding of less than 15mm AP diameter. 
Anecdotally, in the early pregnancy clinic, there has been a tendency to rely more on 
ultrasound findings rather than clinical findings, and a blood clot can sometimes 
appear like products for an inexperienced provider.  
The patient flow diagram, Figure 3, shows that of the patients who chose medical 
management, 75% will complete the miscarriage in that category. The completion rate 
of women who initially chose expectant management is low (18.4%). This may be 
explained by some of them having pregnancies of undetermined viability initially 
where women chose to wait in the hope that the pregnancy might still continue, or 
these women needed time to process the information and consider their options. 
The complication rate was the highest in the surgical group, with 32% having at least 
one complication which included 26% who received blood transfusions, 12% had 
sepsis, and 2% required re-evacuation. This high complication rate is a reflection of 
the 66% of women within the surgical group being unstable at initial presentation 
whose appropriate management was surgical evacuation rather than complication of 
the surgical evacuation procedure itself. No patient within this group had a procedure 
related complication namely uterine perforation or cervical trauma23. The medical 
group had an overall complication rate of 9.5%, spread equally between blood 
transfusion, sepsis and drug side effects. Expectant management was safest with only 
2.3% complication rate which is a reflection of the nature of the miscarriage in 
women with prolonged heavy bleeding electing to complete their miscarriage either 
medically of surgically with only 30% of women who initially chose expectant 
management completing their miscarriage in this group. 
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Strengths and limitations 
Strengths of the study involved the inclusion of both stable and unstable patients, 
which is important in the South African context where miscarriages still carry 
significant morbidity and mortality. Another strength was that patients who were 
eventually lost to follow-up were kept in the analysis as long as possible, even if the 
last visit did not occur. 
Methodological limitations were information bias with several missing files. 
Measurement bias could have been an issue as different clinicians conducted scans on 
follow-up, causing potential inter-rater variability. Other limitations included loss to 
follow-up, which is difficult to overcome. Specifically sampling a small number of 
the group of lost patients to see what happened would have been one way to 
overcome this.  
Study in perspective 
The complication rate is higher in comparison with studies done in Africa. Bique et 
al. from Mozambique who compared 600mcg misoprostol (medical evacuation) vs 
surgical evacuation of miscarriages, observed only one case each of sepsis and 
haemorrhage out of 270 women.24 Dao et al. in Burkhina Faso compared the same 
methods and reported one blood transfusion and one case of sepsis out of 447 women 
in 2007.25 Weeks et al. compared medical vs surgical methods in Kampala Uganda in 
317 women, of which one required laparotomy for acute abdomen with a pelvic 
abscess, four had sepsis, five had cervical trauma, and no blood transfusions were 
reported.26 It is important to note that these studies were done under strict trial 
conditions and excluded unstable patients, where as the index study includes a high 
rate of unstable patients, which reflects a real-life situation and current practice at our 
institution. Many studies did not objectively report on complication rates, but rather 
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on women’s perceptions of bleeding, pain and side effects. This is difficult to interpret 
as it is unknown whether the bleeding was significant enough to require admission or 
transfusion, the infection severe enough to require admission and antibiotics and the 
side effects severe enough to necessitate admission.6,27 The surgical evacuation rate 
for medically managed patients was 19% and for expectantly treated patients it was 
34%. 
Patients lost-to-follow-up is not an unknown problem, with Weeks et al. in Uganda 
reporting a 40% loss-to-follow-up.26 Loss to follow up may indicate that these women 
experienced barriers to returning and thus might have experienced an unrecognized 
complication, or returned to a different facility with their problem, or their 
miscarriage resolved spontaneously without complications and they chose not to 
return due to this. These patients should be the focus of future research to find out 
why they do not return and look for ways to improve this.  
Returning for follow-up visits can be both costly and logistically challenging for a 
socioeconomically deprived population. Rather than seeing the noted protocol 
violations as solely failure of protocol compliance, they highlight areas of challenges 
in service delivery and access to healthcare, particularly clinicians’ need to be able to 
do safe surgical evacuations under local anesthetic in a timely manner ideally in a 
convenient setting. At this institution, a procedure room open for use 24 hours with 
adequate staffing and equipment would aid service delivery. Also, de-centralising this 
basic service to district hospital setting for stable patients, would both make the 
waiting time to be evaluated and managed shorter. It would also ease the workload at 
the referral-hospitals as the delay in management often leaves the patient in need of 
more resuscitation and at risk of suffering from complications. This has been 
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addressed in the ESMOE guidelines used to train health care professionals working at 
all levels from primary care settings up to tertiary hospitals.  
Surgical management is the most effective management in our context, but in the 
appropriately selected patient who is able to follow up, medical and expectant 
management are good alternatives. 
Future focus areas 
Patient satisfaction was not assessed in this study, and would be a valuable next step 
to consider in a resource-constrained context, to allow further improvement of 
services. The protocol made a difference in terms of the management options 
becoming clearer for clinicians and patients alike, and giving staff the confidence to 
manage these patients, and for patients knowing there was a safety net and a follow-
up plan available. Auditing the outcomes gave a unique picture of how the service 
runs, and how it might be improved upon. Continuous training of health care 
professionals in management of first trimester miscarriages should remain a focus, 
and regular auditing should be carried out to ensure a safe service. Enabling effective 
service provision at the appropriate level of care can also help improve the service by 
having the patient managed timeously, and locally when possible. 
 
Conclusion 
Modern management of first trimester miscarriages was implemented for the first 
time according to a specific protocol within Tygerberg Hospital, a secondary and 
tertiary level hospital within the Cape Town Metropole, and has given the department 
a safe framework to treat patients. In addition, it offers patients the choice of 
treatment. 
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Appendices 
Appendix 1 
		 	
! 1!
 
 
 
 
Protocol for the Management of a First Trimester Miscarriage (<13 weeks) 
 
Aim: to manage early pregnancy loss in an outpatient setting, thereby providing women with alternatives 
other than routine surgical uterine evacuation and performed in a setting chosen by the woman. 
 
Contents 
Terminology and transvaginal ultrasound criteria for diagnosing miscarriage; with clinical 
correlation findings .................................................................................................................... 1!
MANAGEMENT ........................................................................................................................ 2!
Initial assessment and workup of miscarriage: ......................................................................... 2!
DETERMINE IF IT IS A SAFE/STABLE OR UNSAFE/UNSTABLE MISCARRIAGE: .............. 3!
MANAGEMENT OF UNSAFE MISCARRIAGES ...................................................................... 3!
MANAGEMENT OF SAFE MISCARRIAGES ........................................................................... 4!
Early Pregnancy loss (Missed miscarriage/delayed miscarriage or Empty sac) ....................... 4!
Incomplete miscarriage ............................................................................................................. 4!
Complete miscarriage ............................................................................................................... 5!
FOLLOW-UP ............................................................................................................................. 6!
COUNSELLING ........................................................................................................................ 6!
 
 
In all cases: 
• Ensure that the correct diagnosis has been made 
• Decide if the patient has a safe or unsafe miscarriage 
• All women should be adequately counselled on their options for miscarriage management, family 
planning and future fertility 
• A safety net should be provided in terms of scheduled or unscheduled follow-up appointments 
 
 
Terminology and transvaginal ultrasound criteria for diagnosing miscarriage; with clinical 
correlation findings 
Diagnostic term Ultrasound criteria Clinical findings 
Pregnancy of 
uncertain viability 
Presence of an intrauterine gestation sac 
(GS) of less than 25mm in which an 
embryo or yolk sac is not seen 
OR  
Embryo with CRL ≤ 7mm with no heart 
activity 
 
Minimal vaginal Bleeding or pain, closed 
cervix 
Early pregnancy 
loss/ 
Delayed/Missed 
miscarriage 
 
Embryo with CRL ≥ 7mm with no visible 
heart activity (may be referred as an 
embryonic loss if <9wk6/7/ CRL <10mm 
or a fetal loss if ≥10wk0/7/ CRL >30mm) 
OR 
The presence of an embryo of less than 
7mm in which fetal heart is not visible 
when repeat scan is performed after at 
Minimal vaginal Bleeding or pain, closed 
cervix 
TYGERBERG HOSPITAL 
Department of Obstetrics and Gynaecology: General Specialist Services !
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! 2!
least 7 days (may also be referred to as 
an embryonic loss) 
OR 
Gestational sac with a mean sac 
diameter greater than or equal to 25mm 
with no visible embryo or yolk sac (also 
termed empty sac) 
 
Incomplete 
miscarriage 
Irregular heterogeneous echoes within 
the endometrial cavity, anterior-posterior 
(AP) endometrial lining > 15mm 
 
Passage of some pregnancy–related 
tissue and/or bleeding and/or abdominal 
pain, open cervix 
Complete 
miscarriage 
The ultrasound finding of an empty uterus 
after initial visualization of an intrauterine 
GS (with or without embryo) with AP 
endometrial lining of < 15mm 
Or 
The ultrasound finding of an empty uterus 
in association with a positive pregnancy 
test, followed by rapid decrease in serum 
βHCG levels (also known as failed 
pregnancy of unknown location; as failed 
ectopic pregnancy cannot be ruled out) 
 
Cessation of vaginal bleeding & 
abdominal pain, closed cervix 
 
 
MANAGEMENT  
Initial assessment and workup of miscarriage: 
o The Early Pregnancy Assessment Checklist  should be used for note keeping in all patients 
presenting C2A gynaecological emergency centre and with a pregnancy test positive 
o Obtain a good history of any vaginal bleeding or pain; including risk factors for ectopic 
pregnancy. 
o Check booking bloods if patient is booked (Rh, syphilis, HIV 
! Offer rapid HIV for all pregnant patients if status unknown. 
! Perform rapid Rhesus and syphilis test in all women presenting with problems in  
early pregnancy if not known 
o General examination: 
! Vital signs (Temperature, Blood pressure, Heart rate, Respiratory rate) urine 
diagnostic strips, urine pregnancy test. 
! Cardiovascular, respiratory and abdominal examination.  
o Specific examination:  
! Assess vaginal bleeding by speculum and bimanual examination. 
! Speculum examination:  
• Examine cervical os: open or closed? Macroscopically normal or not?  
• Offensive discharge? 
• Presence of necrotic cervical tissue/ cervical trauma? 
" If there are products in the os, gently remove it with ovum forceps; 
especially if there are signs of shock as this might contribute to cervical or 
haemorrhagic shock. 
! Bimanual examination:  
• Check for cervical excitation tenderness, the size of the uterus, any adnexal 
masses or tenderness 
o Determine correct gestation by ultrasound (CRL, GS size), and diagnose type of miscarriage 
as per ultrasound criteria  with transvaginal scan. It is advisable to obtain a second opinion 
on ultrasound when diagnoses of early pregnancy loss (Missed miscarriage/delayed 
miscarriage or Empty sac) to ensure no false positives of an otherwise viable pregnancy or 
otherwise a repeat scan should be considered in 7 days. 
o Extra investigations 
! Ward Hb 
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! If rapid Rhesus status is negative then blood for Rhesus antibodies should be taken 
in ALL pregnant women to asses prior sensitization  Give 50µg (250iu) Anti-D 
Immunoglobulin if Rhesus negative with no antibodies present in cases of ectopic, 
surgical evacuation, medical evacuation and complete miscarriages after 12wk 0/7. A 
dose of 100µg (500iu) can also be given if unable to split the ampule BUT this dose 
must be given if >20wks. ONLY spontaneous, complete miscarriages <12wk DO 
NOT require ant-D Immunoglobulin A Kleihauer test for fetal maternal haemorrhage  
is not necessary in the first trimester. 
! βHCG if pregnancy of unknown location 
 
DETERMINE IF IT IS A SAFE/STABLE OR UNSAFE/UNSTABLE MISCARRIAGE: 
 
ANY ONE of the following criteria indicates an unstable patient/unsafe miscarriage 
Vital signs Temperature > 37.5°C 
Systolic blood pressure < 90mmHg 
Diastolic blood pressure <50mmHg 
Heart rate >90 beats per minute 
Respiratory rate > 20 per minute 
Clinical 
examination: 
Uterus > 12w size  
Foul smelling discharge/products of conception 
Clinical signs of infection 
Organ dysfunction or shock 
Investigations Haemoglobin < 10 g/dl 
 
MANAGEMENT OF UNSAFE MISCARRIAGES  
Unstable patient with incomplete miscarriage or delayed miscarriage:  
 
• Investigations and Interventions will be dependent on whether there is sepsis or 
haemorrhagic shock 
• Get IV access. 
• Do arterial blood gas, full blood count, creatinine and electrolytes if septic or shocked 
• Do blood culture, midstream urine culture, if source of sepsis unclear /unknown 
• Consider Chest X-ray if clinically indicated. 
• Start IV fluid resuscitation with crystalloids. 
• Start IV antibiotics if septic: 
o 3rd generation cephalosporin, e.g. Ceftriaxone 1g daily OR  Ampicillin 2g 6 
hourly OR Clindamycin 600mg 8 hourly intravenously 
PLUS 
Metronidazole 500mg 8 hourly intravenously or 400mg 8 hourly orally 
PLUS  
Gentamicin 5-6mg/kg daily intravenously (ensure normal creatinine) 
• Patient must be reviewed by a registrar within 1 hour after presentation and booked for 
Manual Vacuum Aspiration (MVA)/suction curettage in C2A theatre (haemorrhagic 
shock) or main theatre (septicaemia).  The case must be discussed prior with the 
anaesthetist  
• Only stable/ safe miscarriages can be performed in gynaecology day theatre (GEK). 
 
" If there is ONLY a Vaginal discharge, no clinical signs of sepsis :  
• Give Doxycycline 100mg twice daily orally for 7 days (if the pregnancy is viable, give 
Azithromycin 1g single dose orally instead) 
PLUS 
Cefixime 400mg single dose orally OR Ceftriaxone single dose 250mg intramuscularly  
PLUS 
Metronidazole 2g single dose orally 
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MANAGEMENT OF SAFE MISCARRIAGES 
• Explain risks and benefits of each management option i.e. expectant, medical and surgical (see 
table below) 
• Obtain consent and document patient choice 
Give contact number of C2A and inform of 24 hour availability of the emergency center.  !
Early Pregnancy loss (Missed miscarriage/delayed miscarriage or Empty sac) 
o Expectant management – Success rate 28- 76% 
! Ensure patient is stable/safe. 
! Follow up in 1-2 week (Tuesday walk-in clinic) unless heavy or prolonged bleeding in 
the interim. 
! Rescan if still bleeding or bleeding has not yet started. If patient had passed products 
and stopped bleeding, a scan is not needed. 
! If GS still seen or endometrium >15mm, offer Surgical Evacuation or medical 
management. If the patient declines this: rescan 2 weekly until complete, if patient 
remains stable and is willing to continue expectant management. 
! If pregnancy test still positive on DC from TBH: Pregnancy test in local clinic 3 weeks 
later. Return to TBH if positive. (This is to ensure that no molar pregnancy or 
ectopic pregnancy is missed) 
 
 
o Medical management – Success rate 52-92% 
! Ensure patient is stable/safe and that there is NO contraindication to misoprostol 
(see table below). 
! Advice about bleeding/infection. 
! Remove IUCD if in situ. 
! Give misoprostol 800 micrograms sublingually. Inform the patient to return the 
following day (to C2A Emergency Center) if bleeding did not occur. Patient can be 
given another dose of 800 micrograms sublingually 24h after first dose if no bleeding 
has occurred. 
! Follow up in 1-2 week (Tuesday walk-in clinic) unless heavy or prolonged bleeding in 
the interim. 
! Rescan if still bleeding or bleeding has not yet started. If patient had passed products 
and stopped bleeding, a scan is not needed  
! If GS still seen or endometrium >15mm, offer Surgical Evacuation. If the patient 
declines this, offer repeat medication or expectant management and rescan 2 weekly 
until complete, if patient remains stable and is willing to continue. 
! If pregnancy test still positive on DC from TBH: Pregnancy test in local clinic 3 weeks 
later. Return to TBH if positive 
 
o Surgical management – Success rate 95-100% 
! Check Hb and Rhesus. 
! Book patient with GEK or main theatre for a manual vacuum aspiration (MVA) and 
inform the on-call gynaecology registrar. Any suitably trained health professional can 
perform the procedure. 
! Assess need for cervical priming 
• Misoprostol 400µg sublingually 2-3 hours before MVA. 
• Can repeat Misoprostol 200µg micrograms once 4-6 hours later if the cervix is 
still too unfavourable to do MVA. 
! Advise pregnancy test in local clinic 3 weeks later. Return to TBH if positive. (This is 
to ensure that no molar pregnancy or ectopic pregnancy is missed) 
 
Incomplete miscarriage 
o Surgical management - Success rate 95-100% 
! Check Hb and Rhesus 
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! Book patient with GEK or main theatre and inform on-call gynaecology registrar. Any 
suitably trained health professional can perform the procedure. 
! Assess need for cervical priming 
• Misoprostol 400µg sublingually 2-3 hours before MVA 
• Can repeat Misoprostol 200µg micrograms once 4-6 hours later if the cervix is 
still too unfavourable to do MVA  
! Advise pregnancy test in local clinic 3 weeks later. Return to TBH if positive. (This is 
to ensure that no molar pregnancy or ectopic pregnancy is missed) 
 
o Expectant management – Success rate 80-94% 
! Ensure patient is stable/safe 
! . 
! Follow up in1- 2 weeks (Tuesday walk-in clinic) unless heavy or prolonged bleeding 
in the interim. Rescan if still bleeding or if bleeding has not occurred. If endometrium 
>15mm, offer Surgical Evacuation or Medical management. If the patient declines 
this: rescan 2 weekly until complete, if patient remains stable and is willing to 
continue expectant management. 
! If pregnancy test still positive on DC from TBH: Pregnancy test in local clinic 3 weeks 
later. Return to TBH if positive 
 
o Medical management – Success rate 70-96%  
! Ensure patient is stable/safe and that there is NO contraindication to misoprostol 
(see table below) 
! Consent (explain risks as per Table 3) 
! Advise about bleeding/infection. 
! Remove IUCD if in situ 
! Give misoprostol 600 micrograms SL as single dose.  Patient can be given another 
dose of 600 micrograms sublingually 24h after first dose if no bleeding has occurred. 
! Follow up in 1-2 week (Tuesday walk-in clinic) unless heavy or prolonged bleeding in 
the interim. 
! Rescan if still bleeding or bleeding has not yet started. If patient had passed products 
and stopped bleeding, a scan is not needed  
! If endometrium >15mm, offer Surgical Evacuation. If the patient declines this offer 
repeat medication or expectant management and rescan 2 weekly until complete, if 
patient remains stable and is willing to continue. 
! If pregnancy test still positive on DC from TBH: Pregnancy test in local clinic 3 weeks 
later. Return to TBH if positive 
 
 
The reason for difference in doses of misoprostol between Early Pregnancy Loss (Delayed/ 
Missed/ Empty sac) and Incomplete miscarriage is that the effectiveness of lower dose misoprostol 
in delayed miscarriage is lower, according to Cochrane reviews.  
 
Complete miscarriage 
• A diagnosis of a complete miscarriage can only be made when a prior intrauterine pregnancy 
was seen on ultrasound, OR the fetus was visualized by patient (after passing it vaginally) or 
staff OR visualization of products of conception by attending doctor (need to differentiate from 
blood clots or decidua by clearly identifying villi). 
• If this is not the case, ectopic pregnancy needs to be ruled out by a formal scan in the 
ultrasound department and, following this, it has to be called ‘pregnancy of unknown location’ 
and followed up with serum human chorionic gonadotrophin (βHCG).  
o Do urine βHCG on presentation.  
! If negative and patient has a history of abnormal uterine bleeding further 
investigation is required with follow up at the gynaecological clinic.  
! If positive, draw serum βHCG.  
• If <5 IU/L, patient can be discharged/ referred to gynae clinic  
• If >5IU/L, arrange for a second βHCG to be drawn as per Pregnancy of 
Unknown Location (PUL) protocol, and follow up accordingly.(Refer to 
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Ultrasound Assessment of possible Ectopic Algorithm displayed in 
C2A admissions and Gynae clinic) 
 
FOLLOW-UP 
• Expectant management: follow-up time of one to two weeks has been found to be acceptable to 
patients and result in a 99% rate of complete miscarriage. Patient to come to firm clinic day 
(appointment only) or to the Tuesday walk-in clinic. (Patient remains under initial Firm responsibility if 
MVA required). Ensure that there is a management plan in the folder. 
• Medical management: one to two weeks follow-up time is acceptable and will increase the success 
rate (success implying complete miscarriage) compared with very short intervals such as 24h. Patient to 
come to firm clinic day or to the Tuesday walk-in clinic. (Patient remains under initial Firm responsibility 
if MVA required) 
• Surgical management: only follow up as per patient need. 
• For all patients: open door policy to C2A admissions in cases of prolonged bleeding, high 
temperature, foul smelling discharge etc. 
• Patients should be advised to take a pregnancy test 3 weeks after completion of treatment to ensure 
no ectopic or molar pregnancy is missed. Can be done by local clinic. 
• All patients should have their fertility plans and family planning method assessed, and documented, 
and offered a visit to a family planning clinic after completion. Consider providing a family planning 
method prior to completion when offering expectant or medical management of miscarriages as 
ovulation can occur at 10 days post first trimester miscarriage. Otherwise advise condom usage until 
miscarriage ascertained as complete. 
 
COUNSELLING 
Expectant management involves allowing spontaneous passage of retained products of conception in an 
unprovoked way, i.e. “letting nature take its course”.  
 
Medical management uses drugs like misoprostol, to aid expulsion of retained products.  
 
Surgical management involves taking the patient for a surgical procedure under local anaesthetic to empty 
the uterine cavity; this can either be a manual vacuum aspiration or suction curettage. 
 
Explain logistical barriers that may influence patient choice eg limited access to after hour theatre facilities 
in case of unscheduled evacuation required for heavy menstrual bleeding and the ability of the patient to 
return if heavy bleeding occurs 
 
Risks and benefits of methods 
 
 Expectant 
 
Medical Surgical 
Benefits • Avoids surgical and 
anaesthetic risk 
• Allows women to 
continue daily routine 
• More acceptable to 
some women 
• Avoids surgical and 
anaesthetic risk 
• Faster resolution compared 
with expectant management 
• Planned and predictable 
treatment 
• High success rate 
• Essential  in unstable patient 
Risks • May have more 
prolonged bleeding or 
infection 
• Timescale and outcome 
not always predictable 
• 21-59% may need 
surgical evacuation 
• Risk of unscheduled 
evacuation if heavy 
bleeding occurs and the 
limited availability of 
theatre after hours at 
Tygerberg Hospital 
 
• Greater analgesic need 
• More vaginal bleeding 
• Possible need for surgical 
evacuation in up to 30-40% 
of cases 
• Risk of unscheduled 
evacuation if heavy bleeding 
occurs and the limited 
availability of theatre after 
hours at Tygerberg Hospital 
 
• Side effects of misoprostol: 
diarrhea, vomiting etc. 
• Need for anaesthesia if 
unstable and needing GA 
• Risk of uterine perforation 
and cervical trauma, and 
intrauterine adhesions 
Absolute contra-
indications 
• Heavy vaginal bleeding 
(two pads soaked in an 
• Heavy vaginal bleeding (two 
pads soaked in an hour and 
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hour and then another 
two pads are soaked in 
the next hour) or 
haemodynamic 
instability 
• Anaemia <10g/dl 
• Signs of infection 
(T>37.5, HR>90, foul 
smelling discharge) 
• Suspected ectopic 
 
then another two pads are 
soaked in the next hour or 
haemodynamic instability 
• Anaemia <10g/dl 
• Signs of infection (T>37.5, 
HR>90, foul smelling 
discharge) 
• Suspected ectopic 
• Adrenal insufficiency 
• Long term steroid therapy  
• Porphyria 
• Mitral stenosis 
• NSAID ingestion <48h 
• Haemoglobinpathy  
• Anticoagulant therapy 
• Allergy to misoprostol 
Relative contra-
indications 
 • Hypertension 
• Severe asthma 
• IUCD (remove first) 
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Appendix 2 
 
  
 1 
 
 
 
 
Early Pregnancy Assessment Checklist 
 
Patient sticker 
 
 
Name____________________________________________ 
 
Folder Number____________________________________    
Patient 
information  Vital signs  Examination  
Age   Blood pressure mmHg  Cardiovascular  
Gravidity   Heart rate per minute 
Parity   Temperature °Celsius Respiratory  
Date of LMP   Respiratory rate per minute 
Regular cycles Yes No  Rhesus Positive Negative Unknown Abdomen  
 
Tests   Haemoglobin g/dl Speculum Cervix open Cervix closed 
Urine dipsticks   HIV result Positive Negative Unknown Discharge Yes No 
Pregnancy test Positive Negative  If HIV+, on HAART? Yes No  Products Yes No 
Bimanual Uterine size weeks 
Uterine content 
 
Gestational sac Seen   Not seen Number of sacs 
  
Location of sac Corpus, central 
  
Corpus, excentric Cornu Cervix 
Sac diameters .…...…mm ……...…mm ………….mm Mean: ….….mm 
Double decidual sign Yes No Unsure     
Sac content Empty Yolk sac Embryo Unsure   
Sac contour Regular   Irregular     
Embryo Seen CRL..………mm FHR ………..bpm Not seen   
Other uterine cavity content  Empty  Fluid Tissue AP diameter  
........mm 
Para-uterine findings 
  
Free fluid in POD No Yes Depth…………..mm Clear Turbid 
Left Ovary Normal Corpus luteum Mass:      
Next to left ovary No mass Mass Describe and measure     
Right Ovary Normal Corpus luteum Mass:      
Next to right ovary No mass Mass Describe and measure     
Conclusion - Working diagnosis       
Intrauterine Pregnancy 
Assessment: 
Viable 
Pregnancy* 
Pregnancy of 
uncertain viability 
Early pregnancy 
loss (<13w0d)* 
Late pregnancy 
loss (≥13w0d)* Molar Pregnancy 
Miscarriage Assessment: Incomplete Complete Miscarriage Septic Miscarriage 
Extra uterine pregnancy 
assessment: Possible ectopic Certain ectopic
~ 
Pregnancy of unknown 
location and Other 
(describe): 
 
 
 
TYGERBERG HOSPITAL 
Department of Obstetrics and Gynaecology: General Specialist Services  
Presenting complaint……………………………………………………………………………….. 
………………………………………………………………………………………………………
………………………………………………………………………………………………………
……………………………………………………………………………………………………… 
……………………………………………………………………………………………. 
Ultrasound report 
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PV	bleeding	and	pregnant,	work	up	for	miscarriage	
and	exclude	ectopic	pregnancy:	
•  History	
•  Examina.on	
•  Inves.ga.ons	
•  USS	
•  Vitals:	T	>	37.2,	BP	<	90/50,	HR	>90,	
RR	>	20	
•  Clinical:	Uterus	>	12w	size,	Foul	
smelling	discharge/products	of	
concep.on,	organ	dysfunc.on	or	
shock	
•  Hb<10	
	
Delayed	miscarriage	or	Incomplete	miscarriage	
SAFE	 UNSAFE	
•  If	Sep.c,	manage	as	per	protocol	for	
sep.c	miscarriage	with	IV	An.bio.cs	
and	book	for	EVAC/MVA	
•  If	unsafe	but	not	sep.c,	manage	as	
unsafe	miscarriage	and	book	for	
EVAC/MVA		
Sep.c	miscarriage	
or	other	unsafe	miscarriage	
Expectant	 Medical	 Surgical	
Management	of	First	Trimester	Miscarriage	(<13w)	
	
+	Avoids	surgical	and	anaesthe.c	
risk	
+	Allows	women	to	con.nue	daily	
rou.ne	
	
÷	May	have	prolonged	bleeding	
or	infec.on	
÷	21-59%	may	need	EVAC	
÷	Timescale	and	outcome	not	
always	predictable	
	
+	Avoids	surgical	and	anaesthe.c	
risk	
+	Faster	resolu.on	(cf.	Exp	Mx)	
	
÷	Greater	analgesic	need		
÷	Greater	risk	of	bleeding	
÷	30-40%	may	need	EVAC	
÷	Side	eﬀects	of	misoprostol:	
diarrhoea,	vomi.ng,	headache	
	
+	Planned	and	predictable	
treatment	
+	High	success	rate	
+	Good	in	unstable	pa.ent	
	
÷	Need	for	anaesthesia		
÷	Risk	of	uterine	perfora.on	and	
cervical	trauma,	and	intrauterine	
adhesions		
	
Co
un
se
lin
g	
•  Give	contact	number	and	
C2A	availability		
•  Rescan	1-2	weeks	if	s.ll	
bleeding	or	bleeding	not	
started	
•  At	re-scan,	if	bleeding	and/or	
endometrium	>15mm	at	2	
weeks,	oﬀer	Surgical	or	
Medical	management	
•  If	s.ll	Non-viable	pregnancy:	
rescan	2	weekly	un.l	
complete,	if	pa.ent	remains	
stable	and	is	willing	to	
con.nue	expectant	
management.		
•  Advise	re.	bleeding/infec.on	
•  Remove	IUCD	if	in	situ	
•  Delayed	miscarriage:	Give	
Misoprostol	800	microgram	
PV	in	posterior	fornix,	or	SL	if	
pa.ent	declines	PV.	Inform	
the	pa.ent	to	return	the	
following	day	if	bleeding	did	
not	occur.	Pt	can	be	given	
another	dose	of	800	
micrograms	PV	3-24h	acer	
ﬁrst	dose	if	no	bleeding	has	
occurred.		
•  Incomplete	miscarriage:	Give	
Misoprostol	600	microgram	
PV	in	posterior	fornix,	or	SL	if	
pa.ent	declines,	as	single	
dose.	
•  Check	Hb/Rhesus	
•  Obtain	informed	consent	
•  Book	pa.ent	with	GEK	or	C2A	
theatre	and	inform	on-call	
gynaecology	registrar	.	Any	
suitably	trained	health	
professional	can	perform	
procedure.	
•  If	cervical	priming	needed,	
give	Misoprostol	400μg	PV/	
SL	2-3	hrs	before	MVA.		
•  Can	repeat	Misoprostol	
200μg	micrograms	once	4-6	
hours	later	if	the	cervix	is	s.ll	
too	unfavourable	to	do	MVA		
M
an
ag
em
en
t	
Complete	miscarriage	
Only	diagnosed	when	a	prior	intrauterine	pregnancy	
was	seen	on	ultrasound,	OR	fetus	visualized	by	pa.ent	
OR	visualiza.on	of	products	of	concep.on	by	aiending	
doctor	(need	to	diﬀeren.ate	from	blood	clots	or	
decidua).	
If	this	is	not	the	case	it	has	to	be	called	‘pregnancy	of	
unknown	loca.on’	and	followed	up	with	serum	human	
chorionic	gonadotrophin	(βHCG		
1-2	week	appointment	
Pa.ent	to	come	to	ﬁrm	clinic	day	
or	to	the	Tuesday	MO	clinic.		
As	per	pa.ent	need.		
Fo
llo
w
up
	
1-2	week	appointment	
Pa.ent	to	come	to	ﬁrm	clinic	day	
or	to	the	Tuesday	MO	clinic.		
Follow	up	for	ALL	paFents	
•  Open	door	policy	to	C2A	in	cases	of	prolonged	
bleeding,	high	temperature,	foul	smelling	discharge	
•  Advise	to	do	pregnancy	test	3	weeks	acer	
completed	treatment	to	ensure	no	molar	pregnancy	
missed	
•  Discuss	fer.lity	plans,	and	assess	and	document	
chosen	family	planning	method		
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